FDA approves Zepbound for obstructive sleep apnea | LiveNOW from FOX

FDA approves Zepbound for treating moderate-to-severe obstructive sleep apnea and obesity. Trials show Zepbound reduces breathing disruptions and aids weight loss, but side effects include digestive issues and potential thyroid tumors.